Deals
Sanofi, Pfizer Said to Express Interest in Buying Mexico's Rimsa
- Abbott, Teva, Takeda are also said to have looked at Rimsa
- Mexican maker of generic drugs could fetch about $1 billion
This article is for subscribers only.
Mexican generic-drug company Representaciones e Investigaciones Medicas SA is attracting takeover interest from Sanofi, Pfizer Inc. and Abbott Laboratories, people with knowledge of the matter said.
The Mexico City-based drugmaker, known as Rimsa, also has drawn inquiries from Teva Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Co., said the people, who asked not to be identified because the information is private. Goldman Sachs Group Inc. is managing the sale, in which the company may fetch about $1 billion, the people said.